Daniel A Laheru


Ontology type: schema:Person     


Person Info

NAME

Daniel A

SURNAME

Laheru

Publications in SciGraph latest 50 shown

  • 2019-01 Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2018-12 Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer in NATURE COMMUNICATIONS
  • 2018-02 Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT in ABDOMINAL RADIOLOGY
  • 2018-01 Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective in ANNALS OF SURGICAL ONCOLOGY
  • 2017-08-24 Targeting neoantigens to augment antitumour immunity in NATURE REVIEWS CANCER
  • 2017-04 BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2017-04 Targeting neoantigens to augment antitumour immunity in NATURE REVIEWS CANCER
  • 2017-02 A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor in BRITISH JOURNAL OF CANCER
  • 2015-12 Evaluation of low-dose fractionated radiation therapy as a chemopotentiator of gemcitabine in advanced pancreatic cancer: results from an international multi-institutional phase II trial in JOURNAL OF RADIATION ONCOLOGY
  • 2015-12 Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-09 Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-07 The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience in ANNALS OF SURGICAL ONCOLOGY
  • 2015-05 What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2015-01 A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours in BRITISH JOURNAL OF CANCER
  • 2014-11 A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte–Macrophage Colony Stimulating Factor–Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2014-09 The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma in ANNALS OF SURGICAL ONCOLOGY
  • 2014-08 A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma in INVESTIGATIONAL NEW DRUGS
  • 2014-08 Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001) in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-12 Role of radiotherapy in combination with chemotherapy, targeted therapy, and immunotherapy in the management of pancreatic cancer in JOURNAL OF RADIATION ONCOLOGY
  • 2013-12 Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine in ANNALS OF SURGICAL ONCOLOGY
  • 2013-12 Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships in JOURNAL OF RADIATION ONCOLOGY
  • 2013-04 Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2012-12 Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer in INVESTIGATIONAL NEW DRUGS
  • 2012-12 Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies in INVESTIGATIONAL NEW DRUGS
  • 2012-11 Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making in ANNALS OF SURGICAL ONCOLOGY
  • 2012-04 Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2012-02 A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-10 Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer in INVESTIGATIONAL NEW DRUGS
  • 2011-09 Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2010-12 Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal Pancreas in ANNALS OF SURGICAL ONCOLOGY
  • 2010-11-18 Cancer Vaccines in PRINCIPLES OF ANTICANCER DRUG DEVELOPMENT
  • 2010-08 Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2010-04 Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study in ANNALS OF SURGICAL ONCOLOGY
  • 2008-08 Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2008-08 A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas in INVESTIGATIONAL NEW DRUGS
  • 2008-03 Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2005-12 Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinomad—part 3: Update on 5-year survival in JOURNAL OF GASTROINTESTINAL SURGERY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.21107.35", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239578.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411935.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.94365.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.427738.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.469474.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10586.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.423116.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Laheru", 
        "givenName": "Daniel A", 
        "id": "sg:person.011116610337.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011116610337.10"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1357.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.011116610337.10'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.011116610337.10'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.011116610337.10'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.011116610337.10'


     

    This table displays all metadata directly associated to this object as RDF triples.

    30 TRIPLES      10 PREDICATES      18 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.011116610337.10 schema:affiliation N5513a29b230d4183a794c8eb5963d99a
    2 https://www.grid.ac/institutes/grid.10586.3a
    3 https://www.grid.ac/institutes/grid.239578.2
    4 https://www.grid.ac/institutes/grid.411935.b
    5 https://www.grid.ac/institutes/grid.423116.3
    6 https://www.grid.ac/institutes/grid.427738.d
    7 https://www.grid.ac/institutes/grid.469474.c
    8 https://www.grid.ac/institutes/grid.94365.3d
    9 schema:familyName Laheru
    10 schema:givenName Daniel A
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011116610337.10
    12 schema:sdDatePublished 2019-03-07T13:34
    13 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    14 schema:sdPublisher N774e4ed92677491b8bb72c12bed3e302
    15 sgo:license sg:explorer/license/
    16 sgo:sdDataset persons
    17 rdf:type schema:Person
    18 N5513a29b230d4183a794c8eb5963d99a schema:affiliation https://www.grid.ac/institutes/grid.21107.35
    19 sgo:isCurrent true
    20 rdf:type schema:OrganizationRole
    21 N774e4ed92677491b8bb72c12bed3e302 schema:name Springer Nature - SN SciGraph project
    22 rdf:type schema:Organization
    23 https://www.grid.ac/institutes/grid.10586.3a schema:Organization
    24 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    25 https://www.grid.ac/institutes/grid.239578.2 schema:Organization
    26 https://www.grid.ac/institutes/grid.411935.b schema:Organization
    27 https://www.grid.ac/institutes/grid.423116.3 schema:Organization
    28 https://www.grid.ac/institutes/grid.427738.d schema:Organization
    29 https://www.grid.ac/institutes/grid.469474.c schema:Organization
    30 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...